CN117202903A - 用于增加干细胞功能的尿石素 - Google Patents
用于增加干细胞功能的尿石素 Download PDFInfo
- Publication number
- CN117202903A CN117202903A CN202280028511.7A CN202280028511A CN117202903A CN 117202903 A CN117202903 A CN 117202903A CN 202280028511 A CN202280028511 A CN 202280028511A CN 117202903 A CN117202903 A CN 117202903A
- Authority
- CN
- China
- Prior art keywords
- urolithin
- cells
- stem cell
- hspcs
- population
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Primary Cells (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21172290.5 | 2021-05-05 | ||
| EP21172290 | 2021-05-05 | ||
| PCT/EP2022/061666 WO2022233767A1 (en) | 2021-05-05 | 2022-05-02 | Urolithin for increasing stem cell function |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117202903A true CN117202903A (zh) | 2023-12-08 |
Family
ID=75825544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202280028511.7A Pending CN117202903A (zh) | 2021-05-05 | 2022-05-02 | 用于增加干细胞功能的尿石素 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240228966A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4333832A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024516187A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117202903A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022270331A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023022224A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3213384A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022233767A1 (cg-RX-API-DMAC7.html) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190328703A1 (en) * | 2018-04-30 | 2019-10-31 | Amazentis Sa | Biological enhancer |
| CN111093656A (zh) * | 2017-09-15 | 2020-05-01 | 小利兰·斯坦福大学托管委员会 | 用于保护、扩增造血干细胞和提高造血干细胞效力的线粒体醛脱氢酶2调节剂 |
| WO2020148445A1 (en) * | 2019-01-18 | 2020-07-23 | Société des Produits Nestlé S.A. | Agents and methods for increasing stem cell function |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5723315A (en) | 1996-08-23 | 1998-03-03 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
| CZ297278B6 (cs) | 1996-08-07 | 2006-10-11 | Darwin Discovery Limited | Deriváty hydroxamové a karboxylové kyseliny a jejich pouzití |
| US6126939A (en) | 1996-09-03 | 2000-10-03 | Yeda Research And Development Co. Ltd. | Anti-inflammatory dipeptide and pharmaceutical composition thereof |
| WO2019163176A1 (ja) * | 2018-02-21 | 2019-08-29 | 株式会社ダイセル | ウロリチン類を含有する破骨細胞分化抑制剤 |
-
2022
- 2022-05-02 AU AU2022270331A patent/AU2022270331A1/en active Pending
- 2022-05-02 CA CA3213384A patent/CA3213384A1/en active Pending
- 2022-05-02 EP EP22726708.5A patent/EP4333832A1/en active Pending
- 2022-05-02 BR BR112023022224A patent/BR112023022224A2/pt unknown
- 2022-05-02 JP JP2023565251A patent/JP2024516187A/ja active Pending
- 2022-05-02 CN CN202280028511.7A patent/CN117202903A/zh active Pending
- 2022-05-02 US US18/558,802 patent/US20240228966A1/en active Pending
- 2022-05-02 WO PCT/EP2022/061666 patent/WO2022233767A1/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111093656A (zh) * | 2017-09-15 | 2020-05-01 | 小利兰·斯坦福大学托管委员会 | 用于保护、扩增造血干细胞和提高造血干细胞效力的线粒体醛脱氢酶2调节剂 |
| US20190328703A1 (en) * | 2018-04-30 | 2019-10-31 | Amazentis Sa | Biological enhancer |
| CN112512517A (zh) * | 2018-04-30 | 2021-03-16 | 阿马曾提斯公司 | 作为免疫增强剂的尿石素a |
| WO2020148445A1 (en) * | 2019-01-18 | 2020-07-23 | Société des Produits Nestlé S.A. | Agents and methods for increasing stem cell function |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022270331A9 (en) | 2023-10-19 |
| JP2024516187A (ja) | 2024-04-12 |
| US20240228966A1 (en) | 2024-07-11 |
| AU2022270331A1 (en) | 2023-10-12 |
| CA3213384A1 (en) | 2022-11-10 |
| WO2022233767A1 (en) | 2022-11-10 |
| EP4333832A1 (en) | 2024-03-13 |
| BR112023022224A2 (pt) | 2024-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hoorweg et al. | Functional differences between human NKp44− and NKp44+ RORC+ innate lymphoid cells | |
| JP7677893B2 (ja) | 幹細胞機能を向上させるための薬剤及び方法 | |
| Kurtzberg et al. | Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases | |
| CN107072975A (zh) | 用于造血干细胞药物中的方法和化合物 | |
| AU2017414804B2 (en) | Selection and use of umbilical cord cell fractions suitable for transplantation | |
| AU2018270407B2 (en) | Selection and use of umbilical cord cell fractions suitable for transplantation | |
| US20240010981A1 (en) | Compositions and methods for increasing stem cell function | |
| US20230365933A1 (en) | Compositions and methods for increasing stem cell function | |
| HK40104930A (en) | Urolithin for increasing stem cell function | |
| US20240228966A1 (en) | Urolithin for increasing stem cell function | |
| CN119899800A (zh) | 从iPSC诱导分化NK细胞的方法 | |
| HK40058827A (en) | Agents and methods for increasing stem cell function | |
| CN101160391A (zh) | 获得人造血干细胞群体的方法 | |
| HK40096626A (en) | Compositions and methods for increasing stem cell function | |
| HK40095240A (en) | Compositions and methods for increasing stem cell function | |
| Kurtzberg et al. | Reprint of: Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases | |
| Filip et al. | Homing of lin−/CD117+ hematopoietic stem cells | |
| CA3063674C (en) | Selection and use of umbilical cord cell fractions suitable for transplantation | |
| Imanirad et al. | HIF1α is a regulator of hematopoietic progenitor and stem cell development |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40104930 Country of ref document: HK |